Partner Article
Macclesfield-based Redag wins major R&D deal
Macclesfield-based Redag Crop Protection has signed a major R&D agreement with one of the top ten players in the agrochemical market, who cannot be named, to collaborate on the development of new pesticides.
Redag Crop Protection will give exclusive access to two of its areas of chemistry and will apply its methodology to create compounds with the potential to become new products.
In return, Redag will receive multiple six-figure payments.
Redag will enter into a development agreement with its partner for some of these compounds in exchange for multi-million milestone payments and royalties on sales.
CEO of Redag Crop Protection, Bill Thompson, said: “Following the fundraising in October 2014 we have established our chemistry team in Alderley Park, Cheshire and continued to develop our science.
“Having successfully demonstrated the technical proof of our approach to key companies in the industry, this first collaboration underlines that commercial value.
“Both parties to the agreement see this as a first step in a long-term relationship. It is a significant milestone in our progress and reinforces Redag’s position as the engine of discovery in the crop protection market.”
The deal comes less than nine months after Redag demerged from its parent company Redx Pharma and moved into new premises in Alderley Park.
This was posted in Bdaily's Members' News section by Sophia Taha .
The rise of an alternative investor model
Bots don't beat personal business coaching
From COVID-19 to the Middle East crisis
How to build credibility in B2B marketing
Is your business ready for the trade union change?
Government 'must take its foot off businesses' throats'
Upskilling key to civil engineering's future
Why apprenticeships are becoming a strategic asset
Business growth requires the right environment
OpenAI decision a wake-up call for our tech plans
Understanding the new Employment Rights Act
Why global conflict is a cyber risk for UK SMEs